3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Leukemia
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
asciminib
2
venetoclax
1
gilteritinib
1
fludarabine phosphate
1
fludarabine
1
blinatumomab
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
nilotinib
×
30 days
×
Clear all
No trials found.